Biomarkers
/
Metabolic Health
/
NON-HDL Total Cholesterol Ratio

NON-HDL Total Cholesterol Ratio

The Non-HDL / Total Cholesterol ratio measures the proportion of your total cholesterol that is carried by potentially harmful lipoproteins - all cholesterol excluding HDL, which is considered “good cholesterol.
Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.
Book your test now
Book a NON-HDL Total Cholesterol Ratio Test
With Superpower, you have access to a comprehensive range of biomarker tests
Physician reviewed
CLIA-certified labs
HIPAA compliant

Key benefits of Non-HDL Cholesterol / Total Cholesterol (Mass Ratio) testing

  • Shows what fraction of your cholesterol is potentially harmful to arteries.
  • Flags cardiovascular risk more completely than LDL alone, especially after meals.
  • Guides lipid-lowering therapy by tracking all atherogenic particles in one number.
  • Clarifies risk when triglycerides are high and LDL calculations become less reliable.
  • Tracks treatment progress over time to protect heart and vascular health.
  • Helps identify familial lipid disorders that increase early heart disease risk.
  • Best interpreted alongside HDL, triglycerides, and your personal cardiovascular risk factors.

What is Non-HDL Cholesterol / Total Cholesterol (Mass Ratio)?

This biomarker is a calculated ratio that compares all the cholesterol carried by potentially harmful particles to the total amount of cholesterol circulating in your blood. Non-HDL cholesterol includes all cholesterol except the kind carried by HDL (high-density lipoprotein), the protective particle that removes cholesterol from tissues. Total cholesterol is the sum of cholesterol in all lipoprotein particles.

The ratio reveals what proportion of your blood cholesterol is packaged in particles that can deposit fat into artery walls. A higher ratio means a larger share of your cholesterol is traveling in forms that promote plaque buildup, including LDL (low-density lipoprotein), VLDL (very low-density lipoprotein), and remnant particles. A lower ratio suggests more of your cholesterol is in the beneficial HDL form.

It captures the balance between harmful and helpful cholesterol

This single number reflects how much of your cholesterol burden comes from atherogenic (plaque-forming) particles versus protective ones.

It offers a snapshot of cardiovascular risk distribution

The ratio helps clarify whether your total cholesterol is driven more by dangerous or defensive lipoproteins.

It simplifies complex lipid biology into one metric

Rather than tracking multiple cholesterol types separately, this ratio distills your lipid profile into a meaningful proportion.

Why is Non-HDL Cholesterol / Total Cholesterol (Mass Ratio) important?

This ratio reveals what fraction of your total cholesterol is carried by particles that promote arterial plaque. Non-HDL cholesterol includes LDL and all other atherogenic lipoproteins, so a higher ratio means a greater proportion of your cholesterol pool is working against vascular health. It offers a snapshot of lipid balance without requiring a fasting sample.

What a lower ratio tells you about cardiovascular protection

When this ratio sits below 0.70, it signals that HDL cholesterol makes up a larger share of your total pool, reflecting robust reverse cholesterol transport. Your arteries benefit from efficient clearance of excess cholesterol back to the liver. Most people feel no direct symptoms, but long-term cardiovascular risk drops meaningfully.

Why a rising ratio flags hidden plaque risk

Values climbing toward 0.85 or higher indicate that atherogenic particles dominate your lipid profile, even if total cholesterol appears normal. This imbalance accelerates endothelial dysfunction, silent inflammation, and plaque accumulation in coronary, carotid, and peripheral arteries. You may notice no symptoms until a cardiac event occurs.

How this ratio connects lipid metabolism to lifelong health

Because it integrates both harmful and protective cholesterol fractions, this ratio bridges lipid panels with real-world outcomes like heart attack and stroke. Women often show lower ratios before menopause due to estrogen's HDL-boosting effect, while men and postmenopausal women trend higher. Tracking this metric over time helps gauge whether your lipid ecosystem is shifting toward or away from vascular resilience.

What do my Non-HDL Cholesterol / Total Cholesterol (Mass Ratio) results mean?

Low ratio values

Low values usually reflect a lipid profile dominated by HDL cholesterol, the protective fraction that helps remove cholesterol from tissues and vessel walls. This pattern is common in people with naturally high HDL or those taking medications that selectively raise HDL. It generally signals lower cardiovascular risk, though context matters - very low total cholesterol can sometimes accompany malnutrition, chronic illness, or hyperthyroidism.

Optimal ratio values

Being in range suggests a balanced distribution of cholesterol fractions, with non-HDL cholesterol (the sum of LDL, VLDL, and other atherogenic particles) making up a moderate proportion of total cholesterol. Most guidelines consider a ratio below 0.77 favorable, meaning non-HDL accounts for less than 77% of total cholesterol. This reflects adequate HDL protection relative to potentially harmful lipoproteins.

High ratio values

High values usually reflect a lipid profile skewed toward atherogenic particles, with non-HDL cholesterol comprising a large share of total cholesterol. This pattern emerges when HDL is low, LDL or triglycerides are elevated, or both. It signals increased cardiovascular risk and often accompanies insulin resistance, metabolic syndrome, or familial lipid disorders. Women tend to have slightly lower ratios than men due to higher baseline HDL.

Factors that influence interpretation

This ratio is influenced by age, sex, metabolic health, and medications including statins, fibrates, and niacin. Pregnancy typically lowers the ratio as HDL rises. Acute illness can transiently alter lipid distribution.

Get a stable, non-fasting view of atherogenic cholesterol burden to refine heart risk, simplify lipid panels, and guide clear, actionable steps for improvement.

Do I need a Non-HDL Cholesterol / Total Cholesterol (Mass Ratio) test?

Worried about your heart health or family history of cardiovascular disease? Could understanding your cholesterol balance help you protect your heart and prevent future problems?

This ratio reveals the proportion of potentially harmful cholesterol in your bloodstream compared to your total cholesterol. It gives you a clearer picture of cardiovascular risk than total cholesterol alone.

Testing this ratio provides a quick snapshot of your heart health, empowering you to personalize your diet, exercise, and lifestyle choices based on what your body actually needs. It's your first step toward protecting your heart and gaining peace of mind about your cardiovascular future.

Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With on-demand access to a care team, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Method: Derived from FDA-cleared laboratory results. This ratio/index is not an FDA-cleared test. It aids clinician-directed risk assessment and monitoring and is not a stand-alone diagnosis. Inputs: Non-HDL-C, Total-C.

Subscribe for updates
By clicking “Subscribe” you agree to our Terms and Privacy Policy.
Your content is on its way!
By clicking “Subscribe” you agree to our TOS and Privacy Policy.
Oops! Something went wrong while submitting the form.

Similar biomarker tests from Superpower

See more biomarkers

FAQs about NON-HDL Total Cholesterol Ratio

The Non-HDL Cholesterol / Total Cholesterol (Mass Ratio) measures what fraction of your total cholesterol is carried by “bad” or atherogenic particles. Non-HDL cholesterol includes all cholesterol except HDL, so it captures LDL, VLDL, and remnant particles that can deposit cholesterol into artery walls. Dividing non-HDL by total cholesterol produces a proportion that reflects your cholesterol balance, not just a single cholesterol number.

A lower ratio generally means a larger share of cholesterol is HDL (protective), supporting reverse cholesterol transport and lower plaque-forming burden. Many guidelines consider ratios below about 0.77 desirable, with values below 0.65 often reflecting a favorable balance. Higher ratios suggest non-HDL particles dominate total cholesterol, indicating greater atherosclerosis risk. Interpretation is strongest when viewed alongside HDL, triglycerides, and personal cardiovascular history.

This ratio shows what percentage of your cholesterol load is carried by particles linked to plaque buildup and inflammation. Because it includes LDL plus triglyceride-rich particles (VLDL and remnants), it can predict long-term heart attack and stroke risk independent of LDL alone. A higher ratio signals more vessel-damaging lipid transport over time, contributing to endothelial dysfunction and atherosclerotic plaque in coronary, carotid, and peripheral arteries.

LDL measures one atherogenic fraction, while non-HDL includes LDL plus VLDL and remnant particles - everything except HDL. The non-HDL/total cholesterol ratio adds context by showing how much of your total cholesterol is “bad” versus “protective.” It can be especially useful when triglycerides are high or after eating, when standard LDL calculations may be less reliable and risk can be underestimated by LDL alone.

A ratio above 0.80 suggests non-HDL cholesterol dominates total cholesterol, often reflecting excess remnant particles, elevated VLDL, or small dense LDL patterns. Over time, this distribution increases plaque formation risk and can accelerate vascular damage silently before symptoms appear. This shift is common in men over 40 and women after menopause as metabolic and hormonal protection wanes, and it’s often linked to insulin resistance or chronic inflammation.

A ratio below 0.65 typically indicates a greater contribution from HDL cholesterol, suggesting more efficient reverse cholesterol transport and a lower plaque-forming lipid load. Most people have no symptoms at this level; the benefit is long-term vascular protection and lower inflammatory strain on arteries. However, if total cholesterol is very low, it can sometimes be associated with non-lipid issues like malnutrition, liver disease, or hyperthyroidism.

The ratio can rise when triglyceride-rich particles (VLDL and remnants) increase or HDL decreases, even if LDL doesn’t appear markedly elevated. Common drivers include insulin resistance, poorly controlled diabetes, chronic inflammation, thyroid underactivity, and diets high in saturated fat and refined carbohydrates. Hormonal shifts (pregnancy or menopause), changes in body composition, and sedentary habits can also worsen lipid distribution and push the ratio higher.

High triglycerides usually reflect more VLDL and remnant particles, which are included in non-HDL but not fully captured by LDL alone. In these settings, standard LDL calculations can become less reliable, making the non-HDL/total cholesterol ratio helpful for clarifying risk. Because the ratio integrates LDL plus triglyceride-rich lipoproteins, it can better represent the atherogenic cholesterol burden when triglycerides are elevated.

Statins and lifestyle therapy aim to reduce the amount of cholesterol carried by atherogenic particles, lowering non-HDL and improving the ratio. Medications like statins (and sometimes fibrates) can shift lipoprotein distribution and reduce plaque-forming particles. Lifestyle changes - improving diet quality, reducing refined carbohydrates and saturated fat, increasing physical activity, and addressing insulin resistance - can raise HDL contribution and lower VLDL/remnants, improving overall lipid balance.

The ratio is a “snapshot” of lipid distribution, but context determines what it means for you. HDL and triglycerides help explain whether the ratio is driven by low protective HDL or high triglyceride-rich particles (VLDL/remnants). Personal cardiovascular history, age, and hormonal status (e.g., menopause) influence baseline risk and treatment thresholds. Using these markers together gives a clearer picture for guiding heart-protection plans and tracking progress.